ABVD treatment
Showing 1 - 25 of 102
Hodgkin Lymphoma Trial in Italy, United States (Rituximab, Involved field irradiation)
Terminated
- Hodgkin Lymphoma
- Rituximab
- Involved field irradiation
-
Houston, Texas
- +10 more
Aug 18, 2021
Hodgkin Lymphoma, Adult Trial in United States (Brentuximab vedotin, ABVD)
Advanced Classical Hodgkin's Lymphoma in Brazil Treated With
Not yet recruiting
- Hodgkin Lymphoma
- No Intervention
-
Salvador, Bahia, Brazil
- +5 more
Oct 23, 2023
Hodgkin Lymphoma Trial in Italy (Doxorubicin, Bleomycin, Vinblastine)
Active, not recruiting
- Hodgkin Lymphoma
- Doxorubicin
- +3 more
-
Alessandria, Italy
- +45 more
Dec 22, 2022
Hodgkin Lymphoma Trial in Australia, New Zealand (pembrolizumab)
Active, not recruiting
- Hodgkin Lymphoma
-
Concord, New South Wales, Australia
- +5 more
Nov 3, 2022
HIV, Hodgkin's Disease Trial in United States (Vinblastine sulfate, Dacarbazine, Filgrastim)
Completed
- HIV Infections
- Hodgkin's Disease
- Vinblastine sulfate
- +4 more
-
Birmingham, Alabama
- +7 more
Oct 26, 2021
Circulating Tumor DNA Genotyping for Biological Monitoring of
Active, not recruiting
- Hodgkin Lymphoma
-
Avellino, Italy
- +12 more
Dec 22, 2022
Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)
Recruiting
- Hodgkin Lymphoma
- Involved site radiotherapy
- +6 more
-
Aberdeen, United Kingdom
- +6 more
May 24, 2022
Hodgkin Lymphoma, Adult Trial in Moscow (Doxorubicin, Bleomycin, Vinblastine)
Recruiting
- Hodgkin Lymphoma, Adult
- Doxorubicin
- +7 more
-
Moscow, Russian FederationThe Federal Budget-Funded Institution National Medical Surgical
Nov 20, 2020
Hodgkin Lymphoma Trial in France (brentuximab vedotin, Cyclophosphamide, Adriamycin)
Completed
- Hodgkin Lymphoma
- brentuximab vedotin
- +9 more
-
Argenteuil, France
- +29 more
Jul 23, 2021
Hodgkin Lymphoma Trial in Copenhagen (ABVD + FDG-PET/CT Scan treatment adaptation, BEACOPPesc)
Withdrawn
- Hodgkin Lymphoma
- ABVD + FDG-PET/CT Scan treatment adaptation
- BEACOPPesc
-
Copenhagen, DenmarkRigshospitalet
Feb 11, 2021
Ann Arbor Stage IB Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in United
Active, not recruiting
- Ann Arbor Stage IB Hodgkin Lymphoma
- +10 more
- Brentuximab Vedotin
- Nivolumab
-
Palo Alto, California
- +8 more
Jul 20, 2022
Hodgkin Lymphoma Trial in Cologne (ABVD (Adriamycin, Bleomycin, Vincristine, Dacarbazine), 20 Gy IFRT (Involved Field
Unknown status
- Hodgkin Lymphoma
- ABVD (Adriamycin, Bleomycin, Vincristine, Dacarbazine)
- 20 Gy IFRT (Involved Field Radiotherapy)
-
Cologne, Germany1st Dept. of Medicine, Cologne University Hospital
Nov 3, 2020
Lymphoma Trial in Nijmegen (drug, radiation, procedure)
Active, not recruiting
- Lymphoma
- ABVD q4 weeks
- +3 more
-
Nijmegen, NetherlandsUniversitair Medisch Centrum St. Radboud - Nijmegen
Feb 2, 2021
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Pediatric Hodgkin's Disease Trial in Buenos Aires (No radiotherapy if CR at the end of chemo., Low risk with complete early
Recruiting
- Pediatric Hodgkin's Disease
- No radiotherapy if CR at the end of chemotherapy.
- +8 more
-
Buenos Aires, CF, ArgentinaHospital JP Garrahan
Aug 5, 2019
Hodgkin Lymphoma Trial in Cologne (BEACOPPescalated (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine,
Completed
- Hodgkin Lymphoma
- BEACOPPescalated (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone)
- +3 more
-
Cologne, Germany1st Dept. of Medicine, Cologne University Hospital
Apr 3, 2020
Classical Hodgkin Lymphoma, Hodgkin Lymphoma (Category), Hodgkin Disease Trial in Riyadh (Adriamycin, Cyclophosphamide,
Unknown status
- Classical Hodgkin Lymphoma
- +3 more
- Adriamycin
- +5 more
-
Riyadh, Saudi ArabiaKing Abdulaziz Medical City, Ministry of National Guard
Nov 14, 2019
Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)
Completed
- Lymphoma
- bleomycin sulfate
- +12 more
-
Garran, Australian Capital Territory, Australia
- +139 more
Dec 19, 2022
Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)
Completed
- Lymphoma
- Nonneoplastic Condition
- bleomycin sulfate
- +11 more
-
Tucson, Arizona
- +422 more
Aug 16, 2022
Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln
Completed
- Lymphoma, Hodgkin
- +2 more
- Myo-Inositol and D-Chiro-Inositol (MIC)
-
Bari, ItalyIRCCS - Istituto Oncologico"Giovanni PaoloII"
Jun 2, 2022